Sign In
Buy COWN
$38.99
+0 (+0%)
At Close: May 26, 2023
Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Thursday, 27'th Feb 2025
MONTREAL and CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will present at the TD Cowen 45th
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Thursday, 27'th Feb 2025
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today
TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference
07:00am, Thursday, 27'th Feb 2025
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
05:30pm, Wednesday, 26'th Feb 2025
AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.
Puma Biotechnology to Present at TD Cowen's 45th Annual Health Care Conference
04:15pm, Wednesday, 26'th Feb 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will prov
Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
08:30am, Wednesday, 26'th Feb 2025
SAN DIEGO , Feb. 26, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host i
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc . (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that W
Septerna to Present at TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today an
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
PHILADELPHIA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapie
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
IRVINE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladd
CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
ZUG, Switzerland and BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious disea
Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1 bispecific antibody in development for treating solid tumors Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1 b
Korro to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on e
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 26'th Feb 2025
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
Metsera to Present at TD Cowen's 45th Annual Health Care Conference
07:00am, Wednesday, 26'th Feb 2025
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines
